Results 151 to 160 of about 62,419 (246)

A study to evaluate the impact of PB-119 injection (a pegylated exenatide formulation) on the pharmacokinetic profiles of Digoxin and Warfarin sodium in healthy subjects. [PDF]

SAGE Open Med
Yu Y, Hu W, Zhang T, Peng Y, Ding J, Wang X, He H, Zhou D, Han D, Cao J, Cheng N, Zhou J, Zhou H.   +12 more
europepmc   +1 more source

Hyperthyroid heart disease: Diagnostic and therapeutic aspects [PDF]

, 1990
Reinwein, Dankwart, Scriba, P. C., Scriba, Peter Christian   +2 more
core   +1 more source

ECG Changes From Medications [PDF]

, 2012
Ginter, James F., Loftis, Patrick
core   +1 more source

Revisiting Digitalis in Heart Failure: Lessons From DIGIT-HF and Beyond. [PDF]

Circulation
Tarabanis C, Khurshid S, Givertz MM.
europepmc   +1 more source

Regional absorption of talinolol mediated by intestinal transporters: insights from PBPK modeling analysis. [PDF]

Front Pharmacol
Ishida K, Liang X, Buyukozturk F, Hao J, Wan C, Lai Y.   +5 more
europepmc   +1 more source

Multifunctional Bismuth Nanoplatforms Augment Radioactive Iodine Therapy in Anaplastic Thyroid Cancer. [PDF]

Int J Nanomedicine
Qu X, Liu T, Wang Y, Wei X, Yang Y, Gu L, Yang K, Zhang J, Liu Y, Liang Y, Zheng Y, Yang A.   +11 more
europepmc   +1 more source

Physiologically Based Pharmacokinetic Modeling of Digoxin in Adult and Pediatric Patients with Heart Failure. [PDF]

Pharmaceutics
Zhang Y, Liu Y, He H, Hao K.
europepmc   +1 more source

Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. [PDF]

Mol Cancer Ther
Williams KB, Larsson AT, Keller BJ, Chaney KE, Williams RL, Bhunia MM, Draper GM, Jubenville TA, Hudson WA, Georg GI, Moertel CL, Ratner N, Largaespada DA.   +12 more
europepmc   +1 more source

Digoxin Toxicity at Standard Doses in a Child with Subclinical Elevation of Thyrotrophin: A Case Report. [PDF]

Drug Healthc Patient Saf
Khorgami M, Dalili M, Karimian B.
europepmc   +1 more source

Quantification and impact of circulating cardiotonic steroids in the RATE-AF randomised trial of patients with atrial fibrillation and heart failure. [PDF]

BMC Med
Akoumianakis I, Gilligan LC, Bunting KV, Fobian D, Kirchhof P, Arlt W, Taylor AE, Pavlovic D, Kotecha D, Rate control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial team.   +9 more
europepmc   +1 more source